At close: December 20 at 4:00:02 PM EST
After hours: December 20 at 7:37:09 PM EST
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 925.2k | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| FLYNN JAMES E Director and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 12.78 per share. | Indirect | 54,834,085 | Feb 16, 2024 |
| HAMILTON THOMAS EDWARD Director | Purchase at price 12.78 per share. | Direct | 731,118 | Feb 16, 2024 |
| THOMAS FRANK E Director | Purchase at price 11.00 per share. | Direct | 22,000 | Feb 14, 2024 |
| BEN MAIMON CAROLE S Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 17, 2024 |
| CELANO MICHAEL Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 17, 2024 |
| CLAYTON RUSSELL Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 17, 2024 |
| SHANKAR GOPI Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 17, 2024 |
| SHANKAR GOPI Officer | Purchase at price 3.73 per share. | Direct | 18,662 | Dec 7, 2023 |
| TRUITT JOSEPH E Director | Purchase at price 3.73 per share. | Direct | 10,258 | May 17, 2023 |
| BEN MAIMON CAROLE S Chief Executive Officer | Purchase at price 3.70 per share. | Direct | 18,525 | May 17, 2023 |
| CELANO MICHAEL Chief Financial Officer | Purchase at price 3.73 per share. | Direct | 18,632 | May 17, 2023 |
| BEN MAIMON CAROLE S Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2023 |
| CELANO MICHAEL Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2023 |
Related Tickers
CRVS Corvus Pharmaceuticals, Inc.
4.9900
-1.96%
VRDN Viridian Therapeutics, Inc.
19.03
+1.60%
EWTX Edgewise Therapeutics, Inc.
30.78
-0.06%
BMEA Biomea Fusion, Inc.
4.2300
+3.68%
RVPH Reviva Pharmaceuticals Holdings, Inc.
1.3400
-10.67%
FHTX Foghorn Therapeutics Inc.
5.14
+3.21%
CYTK Cytokinetics, Incorporated
48.87
+4.56%
PEPG PepGen Inc.
3.6300
-11.25%
MREO Mereo BioPharma Group plc
3.3500
+1.82%
AFMD Affimed N.V.
1.1900
+0.85%